500124 Stock Overview
Operates as an integrated pharmaceutical company worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
Dr. Reddy's Laboratories Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,193.35 |
| 52 Week High | ₹1,420.20 |
| 52 Week Low | ₹1,074.35 |
| Beta | 0.33 |
| 11 Month Change | -11.60% |
| 3 Month Change | -14.33% |
| 1 Year Change | 6.46% |
| 33 Year Change | 29.54% |
| 5 Year Change | 104.14% |
| Change since IPO | 34,957.23% |
Recent News & Updates
Recent updates
Shareholder Returns
| 500124 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -7.4% | -3.0% | -3.3% |
| 1Y | 6.5% | 42.9% | 27.5% |
Return vs Industry: 500124 underperformed the Indian Pharmaceuticals industry which returned 42.9% over the past year.
Return vs Market: 500124 underperformed the Indian Market which returned 27.5% over the past year.
Price Volatility
| 500124 volatility | |
|---|---|
| 500124 Average Weekly Movement | 2.4% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 500124 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 500124's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 27,048 | Erez Israeli | www.drreddys.com |
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company’s Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business.
Dr. Reddy's Laboratories Limited Fundamentals Summary
| 500124 fundamental statistics | |
|---|---|
| Market cap | ₹994.02b |
| Earnings (TTM) | ₹53.33b |
| Revenue (TTM) | ₹299.87b |
18.6x
P/E Ratio3.3x
P/S RatioIs 500124 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 500124 income statement (TTM) | |
|---|---|
| Revenue | ₹299.87b |
| Cost of Revenue | ₹122.07b |
| Gross Profit | ₹177.80b |
| Other Expenses | ₹124.47b |
| Earnings | ₹53.33b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 64.03 |
| Gross Margin | 59.29% |
| Net Profit Margin | 17.79% |
| Debt/Equity Ratio | 14.2% |
How did 500124 perform over the long term?
See historical performance and comparison